Monamycin B2 (8CI,9CI)(31556-76-0)
- Name: Monamycin B2 (8CI,9CI)
- Synonyms:2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazacyclooctadecine,cyclic peptide deriv.; D-Isoleucine, N-[1-[N-[[2-[[D-hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone;N-[1-[N-[[2-[[D-Hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-isoleucinep-lactone
- Molecular Formula:C33H55 N7 O8
- Molecular Weight:
- CAS Registry Number:31556-76-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 107658-90-2/3-Pentanone, 2-(4-chlorophenyl)-2-hydroxy-4-methyl-1-(1H-1,2,4-triazol-1-yl)-
- 68390-70-5/Rosin, fumaric acid adduct, glycerin ester, p-tert-butylphenol, formaldehyde polymer
- 87252-95-7/3-methylbutyl 3-amino-3-phenylpropanoate hydrochloride
- 63905-75-9/Diheptylacetic acid ethyl ester
- 58749-47-6/5-hydroxy-4-methoxy-2-nitro-benzaldehyde
- 84667-04-9/(1R,6R,10S)-4α,10-Bis(acetyloxy)-5α-[(S)-1,5-dimethyl-4-hexenyl]-2-methylenebicyclo[4.3.1]dec-7-ene-7-carbaldehyde
- 428-65-9/2-Chloro-1,1-difluoro-1-methoxyethane
- 68109-71-7/N-Tridecylglycine
- 133147-06-5/methyl 5-(methoxycarbamoyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
- 67801-11-0/5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol
- 78812-05-2/[(6-methylquinolin-4-yl)(phenylammonio)methylidene]ammonium dichloride
- 31597-16-7/1,4-Cyclohexanedimethanamine,N,N'-bis[(1,2-dihydro-5-acenaphthylenyl)methyl]-N,N'-dimethyl-,dihydrochloride, trans- (9CI)
- 275-97-8/2l4-Cyclohepta[1,2,5]thiadiazole(9CI)
- 97581-70-9/1-(2-hydroxy-3-propyl-4-{[4-(2H-tetrazol-5-ylmethyl)phenoxy]methyl}phenyl)ethanone
- 63982-07-0/3-(heptanoyloxy)-N,N,N-trimethylanilinium bromide
- 106784-36-5/1,1'-Decamethylenebis[3-phenylquinuclidiniumbromide] (7CI)
- 114691-27-9/airodent-02
- 18794-33-7/Pyridine, 3-(methylthio)- (6CI,8CI,9CI)
- 5347-50-2/1-(4-bromophenyl)-2-[(6-nitro-1H-benzimidazol-2-yl)sulfanyl]ethanone
- 31556-76-0/Monamycin B2 (8CI,9CI)
- 32398-63-3/1-ethyl-3,5-diphenyl-1lambda~4~-thiopyran 1-oxide
- 6634-40-8/2-(2-Cyanoethyl)isothiourea monohydrochloride
- 24479-62-7/1'H-Cholest-3-eno[3,4-b]indole(8CI,9CI)
- 55740-64-2/2-amino-5-bromo-6-chloro-1H-pyrimidin-4-one
- 10063-02-2/Pyrrolidinium,1-methyl-1-[(5a,17b)-3-oxoandrostan-17-yl]-, iodide(9CI)
- 84968-74-1/{2-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl}acetic acid
- 1463-77-0/copper(II) cyanide
- 7478-12-8/(1Z)-1-(1,3-benzodioxol-5-yl)-2-phenylethanone oxime
- 6953-04-4/N-(1-methylethyl)-7H-purine-6-sulfonamide
- 395639-58-4/Siloxanes and Silicones, di-Me, hydroxy-terminated, propoxylated, polymers with polypropylene glycol ether with glycerol (3:1), polypropylene glycol ether with pentaerythritol (4:1) and TDI